The present disclosure relates generally to the field of pharmaceuticals. Specifically, thepresent disclosure is directed to a compound SMND-309 for neuro-protective effect againstMPTP-induced Parkinson?s disease via PI3-kinase/Akt pathway.
Gurjeet Thakur, Sandeep Arora, Sonia Dhiman